- Home
- VKTX vs SPNT Comparison
VKTX vs SPNT Comparison
Compare VKTX & SPNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VKTX | SPNT |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | United States | Bermuda |
| Employees | N/A | 1099 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.7B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | VKTX | SPNT |
|---|---|---|
| Price | $28.75 | $23.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $95.86 | $27.50 |
| AVG Volume (30 Days) | ★ 1.9M | 709.5K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $0.85 |
| Revenue Next Year | N/A | $5.85 |
| P/E Ratio | ★ N/A | $5.65 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.96 | $17.17 |
| 52 Week High | $43.15 | $24.32 |
Technical Indicators
Market Signals| Indicator | VKTX | SPNT |
|---|---|---|
| Relative Strength Index (RSI) | 43.67 | 60.34 |
| Support Level | $25.77 | $21.98 |
| Resistance Level | $32.92 | $24.10 |
| Average True Range (ATR) | 1.29 | 0.63 |
| MACD | -0.11 | 0.22 |
| Stochastic Oscillator | 30.67 | 85.69 |
Price Performance
Historical ComparisonAbout VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.